Hemodialysis patients
Conditions
Interventions
Experimental group:Xiaoding cream
Control group:Hirudiod
Sponsors
Gansu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients with chronic renal failure (CKD5) with GFR (ml/min/1.73m2) < 15 and started dialysis; (2) Be between 18~75 years old; (3) Patients undergoing hemodialysis using an arteriovenous fistula. (4) Patients who have created an arteriovenous fistula, and have been diagnosed and treated by hemodialysis for more than 3 months through arteriovenous fistula puncture, and dialysis 3 times a week for 4 hours; (5) Patients with swelling caused by arteriovenous fistula puncture; (6) Patients who sign the informed consent form, have clear consciousness, and have correct language expression.
Exclusion criteria
Exclusion criteria: (1) Those who are allergic to Xiliaoto and anti-definite ointment; (2) Serious cardiopulmonary diseases, coagulation dysfunction and other organ complications; (3) Those involved in other clinical trials during this period; (4) Patients with mental illness or uncooperative patients; (5) Those who have other undesirable factors that hinder the smooth progress of the research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of swelling score;Swelling extent score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue pain scoring;Evaluation of clinical efficacy;Evaluation of complications; | — |
Countries
China
Contacts
Public ContactXu xia
Gansu Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed